According to IMARC Group latest report titledLegionella Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028, offers a comprehensive analysis of the industry, which comprises insights onlegionella testing marketgrowth. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global legionella testing market size reached US$ 285.5 Million in 2022. Looking forward, IMARC Group expects themarket to reach US$ 455.6 Million by 2028, exhibiting a growth rate (CAGR) of 8% during 2023-2028.
What are legionella testing?
Legionella is an infection affecting the lower respiratory tract, which can lead to severe pneumonia, Pontiac fever, and illness with flu-like symptoms. Legionella testing is a diagnostic procedure used to identify the presence of Legionella bacteria in various environments, particularly in water systems. The testing process involves collecting water samples from different sources within the facility and analyzing them for the presence of legionella bacteria. These samples are typically analyzed using culture methods or molecular techniques, including polymerase chain reaction (PCR). The testing helps identifying potential sources of contamination and assess the effectiveness of control measures in place. It assists in ensuring compliance with safety regulations, mitigating potential outbreaks, and protecting public health by enabling timely interventions and proper management of water systems.
Get a Sample Copy of this Report:https://www.imarcgroup.com/legionella-testing-market/requestsample
What are the growth prospects and trends in the legionella testing industry?
The increasing geriatric population is driving the global market. Moreover, the increasing awareness and education among individuals, organizations, and industries such as healthcare, hospitality, and manufacturing are supporting the growth of the market. Besides, various health agencies of numerous countries are developing an effective water safety plan (WSP) to minimize the proliferation of legionella in the water, thus providing a boost to the market. Along with this, recent clinical trials on diagnostic and treatment strategies for adult patients with community-acquired pneumonia are contributing to the growth of the market. Furthermore, escalating international travel and tourism is influencing the testing market as protocols aid in safeguarding the health of guests and maintaining compliance with global health and safety standards.
View Full Report with TOC List of Figure:https://www.imarcgroup.com/legionella-testing-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Abbott Laboratories
- Becton
- Dickinson and Company
- bioMrieux SA
- Bio-Rad Laboratories Inc
- Eiken Chemical Co. Ltd
- Quidel Corporation
- Takara Bio Inc.
- Thermo Fisher Scientific Inc
Legionella Testing Market Segmentation:
Our report has categorized the market based on region, application and end use industry.
Breakup by Application:
- Water Testing
- Microbial Culture
- DFA Stain
- PCR
- Others
- IVD Testing
- Blood Culture
- Urine Antigen Test
- DFA Stain
- PCR
- Others
Breakup by End User:
- Hospitals and Clinics
- Diagnostic Laboratory
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porters Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
